InsidersTradesSigma
Follow the LB PHARMACEUTICALS INC stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €1.6bn. The latest transaction was reported on 9 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Vida Ventures GP III, L.L.C.. Every trade is free.
Analysts rate LB PHARMACEUTICALS INC Strong Buy (bullish), based on 8 analysts. Average price target: US$51.50.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
LB PHARMACEUTICALS INC is a company listed on NASDAQ, specializing in the development of pharmaceutical solutions. It focuses on innovation in the healthcare sector.